Cohort plc Stock
Price
Target price
€16.20
€16.20
3.850%
0.6
3.850%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Cohort
sharewise wants to provide you with the best news and tools for Cohort, so we directly link to the best financial data sources.
Financials
News
Fractyl Health Eyes Q4 Revita Data, Launches Rejuva Gene Therapy Trial
Key Points
- Interested in Fractyl Health, Inc.? Here are five stocks we like better.
- Revita pivotal data are expected in early Q4. Fractyl’s 300-patient trial is testing whether its one-time
Paragon Banking Group H1 Earnings Call Highlights
Paragon Banking Group (LON:PAG) reported what Chief Executive Nigel Terrington called “another strong financial and operational performance” for the first half of 2026, citing resilient margins
CG Oncology Touts Bladder Cancer Data, Q4 Filing Plans at RBC Conference
Key Points
- Interested in CG Oncology, Inc.? Here are five stocks we like better.
- Cohort CX data for cretostimogene plus gemcitabine showed a positive safety and efficacy signal in bladder
CG Oncology BLA Filing on Track as Key Bladder Cancer Data Nears
CG Oncology (NASDAQ:CGON) executives said the company remains on track to complete a rolling biologics license application for
Entrada Therapeutics DMD Trial Shows Early Functional Gains, Clean Safety Profile
Entrada Therapeutics (NASDAQ:TRDA) said initial data from the first cohort of its phase I/II ELEVATE-44-201 trial showed favorable